Low density lipoprotein undergoes oxidative modification in vivo.
AUTOR(ES)
Palinski, W
RESUMO
It has been proposed that low density lipoprotein (LDL) must undergo oxidative modification before it can give rise to foam cells, the key component of the fatty streak lesion of atherosclerosis. Oxidation of LDL probably generates a broad spectrum of conjugates between fragments of oxidized fatty acids and apolipoprotein B. We now present three mutually supportive lines of evidence for oxidation of LDL in vivo: (i) Antibodies against oxidized LDL, malondialdehyde-lysine, or 4-hydroxynonenal-lysine recognize materials in the atherosclerotic lesions of LDL receptor-deficient rabbits; (ii) LDL gently extracted from lesions of these rabbits is recognized by an antiserum against malondialdehyde-conjugated LDL; (iii) autoantibodies against malondialdehyde-LDL (titers from 512 to greater than 4096) can be demonstrated in rabbit and human sera.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=286692Documentos Relacionados
- Probucol inhibits oxidative modification of low density lipoprotein.
- Aspirin protects low density lipoprotein from oxidative modification.
- Cellular oxidative modification of low density lipoprotein does not require lipoxygenases.
- Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo.
- A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
